Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Arnulf

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
The European Respiratory Journal|February 27, 2016
Idelalisib-related pneumonitisEglantine Haustraete, Julie Obert, Samia Diab, et al.
Kidney International|July 16, 2015
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseaseCamille Cohen, Bruno Royer, Vincent Javaugue, et al.
Nature Medicine|April 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Nature Medicine|January 8, 2025
T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Clinical Kidney Journal|February 10, 2021
<b>Kidney transplantation for active multiple myeloma or smoldering myeloma: a case</b>-<b>control study</b>Raphaël Kormann, Claire Pouteil-Noble, Clotilde Muller, et al.
Haematologica|January 18, 2015
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 studyPhilippe Moreau, Halyna Pylypenko, Sebastian Grosicki, et al.
British Journal of Haematology|April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patientsDikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Journal of Medical Virology|May 22, 2025
Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma PatientsSarah Timsit, Guillaume Mellon, Nathalie Forgeard, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Cancer Immunology Research|January 30, 2024
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple MyelomaNathalie Roders, Cecilia Nakid-Cordero, Fabio Raineri, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
The European Respiratory Journal|February 27, 2016
Idelalisib-related pneumonitisEglantine Haustraete, Julie Obert, Samia Diab, et al.
Kidney International|July 16, 2015
Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseaseCamille Cohen, Bruno Royer, Vincent Javaugue, et al.
Nature Medicine|April 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Nature Medicine|January 8, 2025
T cell malignancies after CAR T cell therapy in the DESCAR-T registryRemy Dulery, Vincent Guiraud, Sylvain Choquet, et al.
Clinical Kidney Journal|February 10, 2021
<b>Kidney transplantation for active multiple myeloma or smoldering myeloma: a case</b>-<b>control study</b>Raphaël Kormann, Claire Pouteil-Noble, Clotilde Muller, et al.
Haematologica|January 18, 2015
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 studyPhilippe Moreau, Halyna Pylypenko, Sebastian Grosicki, et al.
British Journal of Haematology|April 8, 2022
Inflammatory Waldenström's macroglobulinaemia: A French monocentric retrospective study of 67 patientsDikelele Elessa, Pierre-Edouard Debureaux, Camille Villesuzanne, et al.
Journal of Medical Virology|May 22, 2025
Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma PatientsSarah Timsit, Guillaume Mellon, Nathalie Forgeard, et al.
Plos One|August 13, 2013
A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patientsSéverine Lecourt, Enguerran Mouly, Delphine Freida, et al.
Cancer Immunology Research|January 30, 2024
Dual Chimeric Antigen Receptor T Cells Targeting CD38 and SLAMF7 with Independent Signaling Demonstrate Preclinical Efficacy and Safety in Multiple MyelomaNathalie Roders, Cecilia Nakid-Cordero, Fabio Raineri, et al.
Pageof 16